Erik Pålsson

3.6k total citations
85 papers, 2.0k citations indexed

About

Erik Pålsson is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Erik Pålsson has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Psychiatry and Mental health, 20 papers in Cellular and Molecular Neuroscience and 19 papers in Molecular Biology. Recurrent topics in Erik Pålsson's work include Bipolar Disorder and Treatment (49 papers), Tryptophan and brain disorders (19 papers) and Adolescent and Pediatric Healthcare (14 papers). Erik Pålsson is often cited by papers focused on Bipolar Disorder and Treatment (49 papers), Tryptophan and brain disorders (19 papers) and Adolescent and Pediatric Healthcare (14 papers). Erik Pålsson collaborates with scholars based in Sweden, United States and United Kingdom. Erik Pålsson's co-authors include Mikael Landén, Carl M. Sellgren, Daniel Klamer, Joel Jakobsson, Caroline Wass, Carl Johan Ekman, Kim Fejgin, Erik Joas, Elizabeth H. Cox and Lennart Svensson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Erik Pålsson

79 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Pålsson Sweden 27 914 574 371 369 253 85 2.0k
Svetlana А. Ivanova Russia 29 966 1.1× 530 0.9× 737 2.0× 813 2.2× 342 1.4× 237 3.2k
Daimei Sasayama Japan 26 563 0.6× 559 1.0× 324 0.9× 161 0.4× 224 0.9× 119 2.1k
Simon Červenka Sweden 26 619 0.7× 482 0.8× 300 0.8× 445 1.2× 273 1.1× 81 2.4k
Blynn G. Bunney United States 18 362 0.4× 437 0.8× 297 0.8× 296 0.8× 212 0.8× 33 2.0k
Antonio Drago Italy 21 405 0.4× 305 0.5× 353 1.0× 330 0.9× 98 0.4× 81 1.4k
Stefan Smesny Germany 31 745 0.8× 475 0.8× 521 1.4× 260 0.7× 412 1.6× 80 2.4k
Giovana Zunta‐Soares United States 32 1.6k 1.7× 724 1.3× 318 0.9× 287 0.8× 156 0.6× 92 2.9k
Abhishekh H. Ashok United Kingdom 19 461 0.5× 410 0.7× 311 0.8× 614 1.7× 131 0.5× 42 1.8k
Lucas B. Rizzo Brazil 24 764 0.8× 716 1.2× 263 0.7× 112 0.3× 251 1.0× 40 1.8k
Gui Ying Wu China 25 617 0.7× 972 1.7× 325 0.9× 327 0.9× 203 0.8× 34 1.8k

Countries citing papers authored by Erik Pålsson

Since Specialization
Citations

This map shows the geographic impact of Erik Pålsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Pålsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Pålsson more than expected).

Fields of papers citing papers by Erik Pålsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Pålsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Pålsson. The network helps show where Erik Pålsson may publish in the future.

Co-authorship network of co-authors of Erik Pålsson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Pålsson. A scholar is included among the top collaborators of Erik Pålsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Pålsson. Erik Pålsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landén, Mikael, Lina Jönsson, Mathias Kardell, et al.. (2025). The St. Göran Project: A Multipronged Strategy for Longitudinal Studies for Bipolar Disorders. Neuropsychobiology. 84(2). 86–99. 4 indexed citations
2.
Pålsson, Erik & Mikael Landén. (2025). Sense of coherence in bipolar disorder– a longitudinal study. BMC Psychiatry. 25(1). 324–324.
3.
Landén, Mikael, Erik Joas, Alina Karanti, et al.. (2025). The Swedish bipolar collection (SWEBIC). International Journal of Bipolar Disorders. 13(1). 20–20.
4.
Jönsson, Lina, Jie Song, Erik Joas, Erik Pålsson, & Mikael Landén. (2024). Polygenic scores for psychiatric disorders associate with year of first bipolar disorder diagnosis: A register-based study between 1972 and 2016. Psychiatry Research. 339. 116081–116081. 1 indexed citations
5.
Sigström, Robert, Erik Joas, Erik Pålsson, et al.. (2024). Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy. Molecular Psychiatry. 30(4). 1601–1609. 3 indexed citations
6.
Joas, Erik, et al.. (2022). Time effect on cardiometabolic risk indicators in patients with bipolar disorder: a longitudinal case–control study. European Archives of Psychiatry and Clinical Neuroscience. 273(5). 1191–1200. 4 indexed citations
7.
Clements, Caitlin C., Anders Juréus, Erik Joas, et al.. (2022). Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter Study. Biological Psychiatry Global Open Science. 3(4). 884–892. 2 indexed citations
8.
Clements, Caitlin C., Robert Karlsson, Yi Lu, et al.. (2021). Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy. Molecular Psychiatry. 26(6). 2429–2439. 32 indexed citations
9.
Sparding, Timea, Erik Joas, Caitlin C. Clements, et al.. (2021). Long-term trajectory of cognitive performance in people with bipolar disorder and controls: 6-year longitudinal study. BJPsych Open. 7(4). e115–e115. 9 indexed citations
10.
Pålsson, Erik, Carl M. Sellgren, Eleonore Rydén, et al.. (2017). Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls. Journal of Neural Transmission. 124(9). 1135–1143. 20 indexed citations
11.
Rolstad, Sindre, Erik Pålsson, Carl Johan Ekman, et al.. (2015). Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder. Bipolar Disorders. 17(8). 859–868. 19 indexed citations
12.
Rolstad, Sindre, Joel Jakobsson, Carl M. Sellgren, et al.. (2015). Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls. PLoS ONE. 10(5). e0127100–e0127100. 36 indexed citations
13.
Zetterberg, Henrik, Joel Jakobsson, Ulf Andréasson, et al.. (2014). Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Research. 217(3). 143–146. 35 indexed citations
14.
Wass, Caroline, Daniel Klamer, Erik Pålsson, et al.. (2011). L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. BMC Medicine. 9(1). 40–40. 18 indexed citations
15.
Klamer, Daniel, Lennart Svensson, Kim Fejgin, & Erik Pålsson. (2010). Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing. European Neuropsychopharmacology. 21(3). 248–253. 7 indexed citations
16.
Pålsson, Erik, John Lowry, & Daniel Klamer. (2010). Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia. Psychopharmacology. 212(4). 643–651. 9 indexed citations
17.
Fejgin, Kim, et al.. (2009). Prefrontal GABAB Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric Oxide. Neuropsychopharmacology. 34(7). 1673–1684. 28 indexed citations
18.
Wass, Caroline, Lennart Svensson, Kim Fejgin, et al.. (2008). Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacology Biochemistry and Behavior. 89(3). 352–359. 19 indexed citations
19.
Pålsson, Erik, Kim Fejgin, Caroline Wass, & Daniel Klamer. (2008). Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition. European Journal of Pharmacology. 590(1-3). 212–216. 27 indexed citations
20.
Wass, Caroline, Trevor Archer, Erik Pålsson, et al.. (2006). Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms. Behavioural Brain Research. 171(1). 147–153. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Svetlana А. Ivanova Breakdown of academic impact, for papers by Daimei Sasayama Breakdown of academic impact, for papers by Simon Červenka Breakdown of academic impact, for papers by Blynn G. Bunney Breakdown of academic impact, for papers by Antonio Drago Breakdown of academic impact, for papers by Stefan Smesny Breakdown of academic impact, for papers by Giovana Zunta‐Soares Breakdown of academic impact, for papers by Abhishekh H. Ashok Breakdown of academic impact, for papers by Lucas B. Rizzo Breakdown of academic impact, for papers by Gui Ying Wu
Rankless by CCL
2026